115 related articles for article (PubMed ID: 16302828)
1. Structure of a synthetic fragment of the lipopolysaccharide (LPS) binding protein when bound to LPS and design of a peptidic LPS inhibitor.
Pristovsek P; Simcic S; Wraber B; Urleb U
J Med Chem; 2005 Dec; 48(24):7911-4. PubMed ID: 16302828
[TBL] [Abstract][Full Text] [Related]
2. Structure of a synthetic fragment of the LALF protein when bound to lipopolysaccharide.
Pristovsek P; Fehér K; Szilágyi L; Kidric J
J Med Chem; 2005 Mar; 48(5):1666-70. PubMed ID: 15743208
[TBL] [Abstract][Full Text] [Related]
3. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood.
Hochart H; Jenkins PV; Preston RJ; Smith OP; White B; O'Donnell J
Thromb Haemost; 2008 Mar; 99(3):570-5. PubMed ID: 18327406
[TBL] [Abstract][Full Text] [Related]
4. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA
J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of endotoxin by human plasma gelsolin.
Bucki R; Georges PC; Espinassous Q; Funaki M; Pastore JJ; Chaby R; Janmey PA
Biochemistry; 2005 Jul; 44(28):9590-7. PubMed ID: 16008344
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide bound structures of the active fragments of fowlicidin-1, a cathelicidin family of antimicrobial and antiendotoxic peptide from chicken, determined by transferred nuclear Overhauser effect spectroscopy.
Bhunia A; Mohanram H; Bhattacharjya S
Biopolymers; 2009; 92(1):9-22. PubMed ID: 18844294
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction.
Araña Mde J; Vallespi MG; Chinea G; Vallespi GV; Rodriguez-Alonso I; Garay HE; Buurman WA; Reyes O
J Endotoxin Res; 2003; 9(5):281-91. PubMed ID: 14577844
[TBL] [Abstract][Full Text] [Related]
8. Identification of single amino acid residues essential for the binding of lipopolysaccharide (LPS) to LPS binding protein (LBP) residues 86-99 by using an Ala-scanning library.
Reyes O; Vallespi MG; Garay HE; Cruz LJ; González LJ; Chinea G; Buurman W; Araña MJ
J Pept Sci; 2002 Apr; 8(4):144-50. PubMed ID: 11991204
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor C competes against LBP to bind lipopolysaccharide and neutralizes the endotoxicity.
Li P; Ho B; Ding JL
J Endotoxin Res; 2007; 13(3):150-7. PubMed ID: 17621557
[TBL] [Abstract][Full Text] [Related]
10. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of truncated human lipopolysaccharide-binding protein in Escherichia coli.
Kohara J; Tsuneyoshi N; Gauchat JF; Kimoto M; Fukudome K
Protein Expr Purif; 2006 Oct; 49(2):276-83. PubMed ID: 16839777
[TBL] [Abstract][Full Text] [Related]
12. A comparison of equine and bovine sera as sources of lipopolysaccharide-binding protein activity in equine monocytes incubated with lipopolysaccharide.
Figueiredo MD; Salter CE; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):275-80. PubMed ID: 18023485
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of TNF-triggering activity of lipopolysaccharide by a proteinaceous factor from normal mouse liver extract.
Satoh M; Matsumura T; Nakamoto M; Yamazaki M
J Immunol; 1995 Jul; 155(2):877-85. PubMed ID: 7608565
[TBL] [Abstract][Full Text] [Related]
14. Interaction between lipopolysaccharide (LPS), LPS-binding protein (LBP), and planar membranes.
Gutsmann T; Haberer N; Carroll SF; Seydel U; Wiese A
Biol Chem; 2001 Mar; 382(3):425-34. PubMed ID: 11347890
[TBL] [Abstract][Full Text] [Related]
15. [Construction of human phage antibody library and screening and characterization of phage antibodies against N terminal fragment of human lipopolysaccharide binding protein].
Ge XD; Liu YS; Wang XD; Wang CS; Deng J; Li H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):180-4. PubMed ID: 15766403
[TBL] [Abstract][Full Text] [Related]
16. Low potency of Chlamydophila LPS to activate human mononuclear cells due to its reduced affinities for CD14 and LPS-binding protein.
Tsutsumi-Ishii Y; Shimada K; Daida H; Toman R; Nagaoka I
Int Immunol; 2008 Feb; 20(2):199-208. PubMed ID: 18056918
[TBL] [Abstract][Full Text] [Related]
17. The crystal structure of lipopolysaccharide binding protein reveals the location of a frequent mutation that impairs innate immunity.
Eckert JK; Kim YJ; Kim JI; Gürtler K; Oh DY; Sur S; Lundvall L; Hamann L; van der Ploeg A; Pickkers P; Giamarellos-Bourboulis E; Kubarenko AV; Weber AN; Kabesch M; Kumpf O; An HJ; Lee JO; Schumann RR
Immunity; 2013 Oct; 39(4):647-60. PubMed ID: 24120359
[TBL] [Abstract][Full Text] [Related]
18. High-resolution solution structure of a designed peptide bound to lipopolysaccharide: transferred nuclear Overhauser effects, micelle selectivity, and anti-endotoxic activity.
Bhattacharjya S; Domadia PN; Bhunia A; Malladi S; David SA
Biochemistry; 2007 May; 46(20):5864-74. PubMed ID: 17469802
[TBL] [Abstract][Full Text] [Related]
19. Histones: a novel class of lipopolysaccharide-binding molecules.
Augusto LA; Decottignies P; Synguelakis M; Nicaise M; Le Maréchal P; Chaby R
Biochemistry; 2003 Apr; 42(13):3929-38. PubMed ID: 12667084
[TBL] [Abstract][Full Text] [Related]
20. Protein fusions of BPI with CETP retain functions inherent to each.
Lloyd DB; Bonnette P; Thompson JF
Biochemistry; 2006 Oct; 45(43):12954-9. PubMed ID: 17059212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
